Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CMS beta testing new mammography-related quality measures

The federal agency is aiming to assess radiologist performance in breast cancer screening and improve patient outcomes.

artificial intelligence federal regulation

US senators seek heightened scrutiny around AI’s use in healthcare

Several experts testified at the Senate Finance Committee inquiry, including two physicians and Siemens Healthineers' head of digital health

Money bankruptcy debt liquidation

Radiology provider Akumin completes bankruptcy process

The Florida-based imaging group has successfully deleveraged from its debts, which totaled some $470 million at the time of the filing in October. 

Thumbnail

After extracting $85M from imaging provider and its CEO, DOJ targets former chief financial officer

Florida resident Rick Nassenstein allegedly “played a central role” in a scheme that involved paying physicians “exorbitant” fees to refer patients for PET scans. 

transthoracic echocardiogram images from 2024 ASE guidelines

American Society of Echocardiography shares updated expert recommendations on pediatric, neonatal echo

These new guidelines provide a fresh look at topics ASE has not addressed with official society recommendations in many years. 

FDA issues Class I recall notice for Philips nuclear imaging system

The alert pertains to its BrightView SPECT family of products, with concerns a loose screw could cause machinery to fall on a patient. 

breast cancer screening mammography

Physician editorialist claims breast cancer screening at 40 will sow confusion; ACR fires back

Russell P. Harris, MD, penned the piece for the Annals of Internal Medicine, spurred by new recommendations issued by the U.S. Preventive Services Task Force. 

Thumbnail

FDA awards breakthrough designation to AI-powered tuberculosis diagnostic tool

A rising number of patients in the U.S. are diagnosed with TB, and AI is being deployed to turn the tide.